S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NKTR Nektar Therapeutics

0.93

0.0222 (2.45%)

Pre Market

Last Updated: 01:27:56

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics News

Form 144 - Report of proposed sale of securities
Friday 27 December 2024 (8 minutes ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 24 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 21 December 2024 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (7 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 20 December 2024 (7 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 18 December 2024 (1 week ago) • Edgar (US Regulatory)

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting
Sunday 8 December 2024 (3 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

More Nektar Therapeutics News Articles

Sterling vs AUD

Australia And New Zealan...

Verizon Communications

Newcrest Mining

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions